Literature DB >> 6652976

The effect of C3 levels on yeast opsonization by normal and pathological sera: identification of a complement independent opsonin.

M A Kerr, J S Falconer, A Bashey, J S Beck.   

Abstract

The ability of 150 normal and pathological sera to opsonize yeast for uptake by isolated human polymorphonuclear leucocytes has been studied. Phagocytosis was measured by an assay depending on electronic particle counting to measure yeast uptake and by a new fluorometric assay which is able to distinguish particle adherence from true phagocytosis. The opsonic activity of normal human serum was heat labile and depended markedly on C3 levels. The sera of 6% of healthy young adults (three from 45) and 8% of healthy donors aged 65-88 (four from 57) showed defective opsonization in spite of normal C3 and CH50 levels. Thirty-eight pathological sera with low C3 levels showed defective opsonization. However, three sera with low C3 levels showed apparently normal opsonic activity. The opsonin from two of these sera was characterized. It was heat stable, had apparent mol.wt of 400,000 and was active in serum free media. The opsonin was absorbed by immobilized Staphylococcus aureus and by gelatin-Sepharose, suggesting that it is related to fibronectin. Fibronectin from normal human sera prepared by affinity chromatography on gelatin-Sepharose was not opsonic in this system.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6652976      PMCID: PMC1536141     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  A defect of the alternative pathway of complement.

Authors:  J F Soothill; B A Harvey
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

Review 2.  Phagocytosis (first of three parts).

Authors:  T P Stossel
Journal:  N Engl J Med       Date:  1974-03-28       Impact factor: 91.245

3.  Single-step separation of red blood cells. Granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque.

Authors:  D English; B R Andersen
Journal:  J Immunol Methods       Date:  1974-08       Impact factor: 2.303

4.  Bactericidal function of human polymorphonuclear leukocytes. E. Mead Johnson Award Address.

Authors:  P G Quie
Journal:  Pediatrics       Date:  1972-08       Impact factor: 7.124

5.  The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable surfaces or phagocytosable particles.

Authors:  P M Henson
Journal:  J Immunol       Date:  1971-12       Impact factor: 5.422

6.  Human immunity to Pseudomonas aeruginosa. I. In-vitro interaction of bacteria, polymorphonuclear leukocytes, and serum factors.

Authors:  L S Young; D Armstrong
Journal:  J Infect Dis       Date:  1972-09       Impact factor: 5.226

7.  Neutrophil receptors for IgG and complement: their roles in the attachment and ingestion phases of phagocytosis.

Authors:  D J Scribner; D Fahrney
Journal:  J Immunol       Date:  1976-04       Impact factor: 5.422

8.  Characteristics of the phagocytic process assessed by Coulter Counter.

Authors:  K E Magnusson; C Dahlgren; O Stendahl; T Sundqvist
Journal:  Acta Pathol Microbiol Scand C       Date:  1977-06

9.  Third component of human complement: purification from plasma and physicochemical characterization.

Authors:  B D Tack; J W Prahl
Journal:  Biochemistry       Date:  1976-10-05       Impact factor: 3.162

10.  Defective opsonization. A common immunity deficiency.

Authors:  J F Soothill; B A Harvey
Journal:  Arch Dis Child       Date:  1976-02       Impact factor: 3.791

View more
  9 in total

1.  Deficiency of mannan binding protein--a new complement deficiency syndrome.

Authors:  M W Turner
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

2.  The level of mannan-binding protein regulates the binding of complement-derived opsonins to mannan and zymosan at low serum concentrations.

Authors:  M Super; R J Levinsky; M W Turner
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

3.  Defective opsonization of Haemophilus influenzae by sera of elderly patients.

Authors:  N D Garbett; G S Matharu; P J Cole
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

4.  Suboptimal C3b/C3bi deposition and defective yeast opsonization. I. Evidence for the absence of essential co-factor activity.

Authors:  M W Turner; N D Seymour; M D Kazatchkine; J F Mowbray
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

5.  Suboptimal C3b/C3bi deposition and defective yeast opsonization. II. Partial purification and preliminary characterization of an opsonic co-factor able to correct sera with the defect.

Authors:  M W Turner; N D Seymour; M D Kazatchkine; J F Mowbray
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

6.  Evaluation of C3b/C3bi opsonization and chemiluminescence with selected yeasts and bacteria using sera of different opsonic potential.

Authors:  M W Turner; C Grant; N D Seymour; B Harvey; R J Levinsky
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

7.  Mannose-binding lectin 2 (MBL2) gene polymorphism in asthma and atopy among adults.

Authors:  J Aittoniemi; H Soranummi; A T Rovio; M Hurme; T Pessi; M Nieminen; J Karjalainen
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

8.  Opsonization of yeast by human serum IgA anti-mannan antibodies and phagocytosis by human polymorphonuclear leucocytes.

Authors:  G R Yeaman; M A Kerr
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

Review 9.  Mammalian lectins in activation and clearance mechanisms involving the complement system.

Authors:  K B Reid; M W Turner
Journal:  Springer Semin Immunopathol       Date:  1994
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.